Gastrointestinal Cancer News

In this Healio video, Rasmi Nair, MBBS, MPH, PhD, reports findings from a recent study, which showed 10% of at-home fecal immunological tests for colorectal cancer screening could not be processed, mostly due to specimen errors.

Researchers at Cleveland Clinic identified differences in tumor-related bacteria that may improve understanding of young-onset colorectal cancer.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

In this video, Rachna T. Shroff, MD, MS, discusses data from the CIRCULATE and COBRA studies, which evaluated the role of circulating tumor DNA in guiding treatment decisions for patients with colon cancer.

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

The FDA approved irinotecan liposome as part of a first-line regimen for the treatment of metastatic pancreatic adenocarcinoma.

Women with concurrent metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease had an 83% greater risk for all-cause mortality than men and those with ALD alone had 160% greater risk, data showed.

Researchers used an artificial intelligence and precision medicine approach that identifies biomarkers that appear superior to standard tests for predicting pancreatic cancer survival, findings in Nature Cancer showed.

Researchers have harnessed the ability of some molecules to vibrate strongly when stimulated by light, potentially laying the groundwork for a new approach to destroying cancer cells.